Cas 86386-73-4 Fluconazole CYP17 Inhibitors Antifungal Medication
Cas 86386-73-4 Fluconazole CYP17 Inhibitors Antifungal Medication
| Product name:Fluconazole | Purity:98% min |
| CAS NO:86386-73-4 | Solubility:DMSO : ≥ 100 mg/mL (326.51 mM) |
| Molecular Formula:C13H12F2N6O | Package:Package according to customer requirements |
| Molecular Weight:306.271 | Storage:Store at -20℃ |
Fluconazole is an antifungal medication that is administered orally or intravenously. It is used to treat a variety of fungal infections, especially Candida infections of the vagina, mouth, throat, and bloodstream. It is also used to prevent infections in people with weak immune systems, including those with neutropenia due to cancer chemotherapy, transplant patients, and premature babies. Its mechanism of action involves interfering with synthesis of the fungal cell membrane.
P450 (e.g. CYP17) inhibitor Related Products:
Abiraterone; Abiraterone acetate; Ketoconazole; Orteronel(racemic); Orteronel; Galeterone; Cobicistat; Ozagrel; Ritonavir; Posaconazole; Voriconazole; Clarithromycin
[1]. Odds, F.C., S.L. Cheesman, and A.B. Abbott, Antifungal effects of fluconazole (UK 49858), a new triazole antifungal, in vitro. J Antimicrob Chemother, 1986. 18(4): p. 473-8.
[2]. Molgaard-Nielsen, D., B. Pasternak, and A. Hviid, Use of oral fluconazole during pregnancy and the risk of birth defects. N Engl J Med, 2013. 369(9): p. 830-9.
[3]. Black, L.A., et al., Pharmacokinetics of fluconazole following intravenous and oral administration to koalas (Phascolarctos cinereus). J Vet Pharmacol Ther, 2013.
Get in Touch
Have questions about our products or want to discuss a custom order? Our team is ready to help you.